News for Healthier Living
Dana-Farber Researchers to Present Two Plenary Studies and Additional Late-Breaking Cancer Research at 2026 ASCO
- Dana-Farber Cancer Institute researchers will present findings at the 2026 Annual Meeting of the American Society of Clinical Oncology (ASCO) from several studies with compelling and potentially practice-changing results spanning multiple cancer types, including pancreatic, prostate, breast, and multiple myeloma.
Investigators will also present additional clinical trial results that support future research into new strategies for the treatment of sarcoma, brain, prostate, and breast cancers.
May 22, 2026
June 3 2026June 2 2026June 1 2026 - Nursing Home Staffing Declined in States That Protected Facilities From COVID-19 Malpractice Lawsuits
- Mount Sinai Researchers Uncover a Substantial Genetic Component to Postpartum Psychosis, Advancing Understanding of Severe Maternal Mental Illness
- Blood Test Shows Promise for Detecting Testicular Cancer When Standard Markers Miss
- UChicago renewed to host NRG Oncology Statistics and Data Management Center for National Cancer Institute
- Clinical Trial Shows Novel Prostate Cancer Treatment Can Reduce Risk of Disease Progression by Half
- Deep Brain Stimulation Remodels Brain Wiring and Alters Functional Changes to Brain-Wide Networks, Landmark Depression Study Reveals
- 7 Trends Reshaping Pediatric Hip Dysplasia Care
- Lab Research Suggests Magnetic Particle Imaging May Help Researchers Find More Effective Ways to Deliver Cell Therapies
- Split Personalities: Researchers Who Bridge Disciplines
- From Fundamental Biology to Treatments for Disease, Stem Cells are Engines of Discovery
- Joan A. Steitz: The 'Queen of RNA' and Her Scientific Feats
- Many Adults with a Normal BMI May Still Have Obesity-Related Health Risks
- Body Mass Index Found to Drastically Underestimate Obesity Levels in the United States
- Your Surprise Medical Bill May Be Gone — But Your Premiums Could Still Spike
- Short-Term Fasting Could Boost Chemo Response in Ovarian Cancer, Study Suggests
- New Analysis Confirms Benefits of Childhood Flu Vaccines
- Hormone Therapy Use for Menopause Declines Despite Proven Benefits, Study Finds
- Powering Every Step: $2M to Develop Knee Exoskeletons for Arthritis Relief, Mobility
- JMIR Report: Digital Platforms and Policy Shifts Reshape GLP-1 Affordability
- Researchers Create First-of-Its-Kind Index of Evolving Policy Landscape Around Health Care AI
- Perfectionism Among College Students Reaches Record High, Fueling Anxiety
- Workout Habits May Protect Against Inherited Heart Problems
- New Survey Results Explore the Complexity of Marijuana Use and Sleep
- Childhood Lying Is Normal and Rarely Signals Behavioral Concerns, Study Says
- Weed Linked To Higher Testosterone Levels In Young Men
- After Her Bout of Amnesia, A $59,000 Billing Dispute Wouldn't Go Away
- Most People Over 50 Have LGBTQ+ Friends or Family, but LGBTQ+ People Over 50 Face More Aging-Related Challenges, Poll Finds
- ASCO: Targeted Therapy Combo Nearly Doubles Time Without Disease Progression for Patients with Advanced Colorectal Cancer
- Virtual Eyes in the Operating Room: AI Detects Surgical Safety Landmark Across Hospitals
- Post-Discharge Antibiotics May Offer Limited Benefit After Pediatric Appendicitis
- Teamwork, Technology Streamline Feeding Tube Placement
- Tomorrow at ASCO 2026: Roswell Park Researchers Spotlight New Insights in Breast Cancer, Myeloma Care and AI
- Study: New Drug Could Dramatically Increase Pancreatic Cancer Survival
- Investigational Targeted Therapy Doubles Survival in Metastatic Pancreatic Cancer
- Targeted Therapy Reduces Risk of Lung Cancer Recurrence by 83% in Rare Genetic Subtype
- Precigen Presents New Long-Term Durability Data for PAPZIMEOS, Recently Granted Seven-Year Market Exclusivity, Demonstrating Complete Responses Beyond 4 Years
- June 2026 Issue of Neurosurgical Focus: "Craniopharyngioma: Contemporary Management"
May 31 2026May 30 2026May 29 2026May 28 2026May 27 2026May 26 2026May 25 2026May 22 2026May 21 2026
|
|
|
|
|